RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS

被引：0
|
作者：
BUZDAR, A [1 ]
SMITH, T [1 ]
MARCUS, C [1 ]
BLUMENSCHEIN, G [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1983年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [31] The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells
    Mentoor, Ilze
    Engelbrecht, Anna-Mart
    van de Vyver, Mari
    van Jaarsveld, Paul J.
    Nell, Theo
    ADIPOCYTE, 2021, 10 (01) : 505 - 523
  • [32] Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
    Putt, Mary
    Hahn, Virginia Shalkey
    Januzzi, James L.
    Sawaya, Heloisa
    Sebag, Igal A.
    Plana, Juan Carlos
    Picard, Michael H.
    Carver, Joseph R.
    Halpern, Elkan F.
    Kuter, Irene
    Passeri, Jonathan
    Cohen, Victor
    Banchs, Jose
    Martin, Randolph P.
    Gerszten, Robert E.
    Scherrer-Crosbie, Marielle
    Ky, Bonnie
    CLINICAL CHEMISTRY, 2015, 61 (09) : 1164 - 1172
  • [33] LONGITUDINAL CHANGES IN MULTIPLE BIOMARKERS ARE ASSOCIATED WITH CARDIOTOXICITY IN BREAST CANCER PATIENTS TREATED WITH DOXORUBICIN, TAXANES AND TRASTUZUMAB
    Hahn, Virginia Shalkey
    Putt, Mary
    Sawaya, Heloisa
    Januzzi, James
    Sebag, Igal A.
    Plana, Juan
    Picard, Michael
    Gerszten, Robed
    Halpern, Elkan
    Kuter, Irene
    Martin, Randolph
    Carver, Joseph
    Scherrer-Crosbie, Marielle
    Ky, Bonnie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A1001 - A1001
  • [34] RADIATION-DOSE AND BREAST-CANCER RISK IN PATIENTS TREATED FOR CANCER OF THE CERVIX
    BOICE, JD
    BLETTNER, M
    KLEINERMAN, RA
    ENGHOLM, G
    STOVALL, M
    LISCO, H
    AUSTIN, DF
    BOSCH, A
    HARLAN, L
    KREMENTZ, ET
    LATOURETTE, HB
    MERRILL, JA
    PETERS, LJ
    SCHULZ, MD
    WACTAWSKI, J
    STORM, HH
    BJORKHOLM, E
    PETTERSSON, F
    BELL, CMJ
    COLEMAN, MP
    FRASER, P
    NEAL, FE
    PRIOR, P
    CHOI, NW
    HISLOP, TG
    KOCH, M
    KREIGER, N
    ROBB, D
    ROBSON, D
    THOMSON, DH
    LOCHMULLER, H
    VONFOURNIER, D
    FRISCHKORN, R
    KJORSTAD, KE
    RIMPELA, A
    PEJOVIC, MH
    KIRN, VP
    STANKUSOVA, H
    PISANI, P
    SIGURDSSON, K
    HUTCHISON, GB
    MACMAHON, B
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (01) : 7 - 16
  • [35] BREAST-CANCER FAMILY HISTORY AS A RISK FACTOR FOR EARLY ONSET BREAST-CANCER
    LYNCH, HT
    WATSON, P
    CONWAY, T
    FITZSIMMONS, ML
    LYNCH, J
    BREAST CANCER RESEARCH AND TREATMENT, 1988, 11 (03) : 263 - 267
  • [36] Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin
    Angel Qin
    Cheryl L. Thompson
    Paula Silverman
    Journal of Cancer Survivorship, 2015, 9 : 252 - 259
  • [37] Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin
    Qin, Angel
    Thompson, Cheryl L.
    Silverman, Paula
    JOURNAL OF CANCER SURVIVORSHIP, 2015, 9 (02) : 252 - 259
  • [38] Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines
    Cocco, D.
    Ferro, E. G.
    Ricci, S.
    Deidda, M.
    Noto, A.
    Madeddu, C.
    Atzori, F.
    Scarlozzi, M.
    Mercuro, G.
    Dessalvi, C. Cadeddu
    EUROPEAN HEART JOURNAL, 2020, 41 : 3289 - 3289
  • [39] Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin
    Erdim, Refik
    Celiker, Aydin
    Gemici, Goekmen
    Tokay, Sena
    Uelfer, Goezde
    Dede, Fuat
    Turhal, Serdar
    Oktay, Ahmet
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2009, 4 (03): : 327 - 330
  • [40] Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study
    De Sanctis, V
    Alfo, M.
    Vitiello, C.
    Vullo, G.
    Facondo, G.
    Marinelli, L.
    Burocchi, S.
    Gallo, G.
    Valeriani, M.
    Campanella, B.
    Scalabrino, G.
    Russo, I
    Salerno, G.
    Cardelli, P.
    Osti, M. F.
    De Biase, L.
    CLINICAL BREAST CANCER, 2021, 21 (03) : E141 - E149
12345